LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 72

Search options

  1. Article ; Online: Andrology: The Male Factor.

    Perheentupa, Antti

    Seminars in reproductive medicine

    2024  Volume 41, Issue 6, Page(s) 211–212

    MeSH term(s) Humans ; Male ; Andrology ; Erectile Dysfunction
    Language English
    Publishing date 2024-03-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2042479-6
    ISSN 1526-4564 ; 1526-8004
    ISSN (online) 1526-4564
    ISSN 1526-8004
    DOI 10.1055/s-0044-1779744
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Andrology: The Male Factor

    Perheentupa, Antti

    Seminars in Reproductive Medicine

    (Andrology)

    2023  Volume 41, Issue 06, Page(s) 211–212

    Series title Andrology
    Language English
    Publishing date 2023-11-01
    Publisher Thieme Medical Publishers, Inc.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2042479-6
    ISSN 1526-4564 ; 1526-8004
    ISSN (online) 1526-4564
    ISSN 1526-8004
    DOI 10.1055/s-0044-1779744
    Database Thieme publisher's database

    More links

    Kategorien

  3. Article ; Online: Male fertility and semen quality are decreasing - Do we have the expertise to deal with this challenge?

    Perheentupa, Antti / Toppari, Jorma

    Acta obstetricia et gynecologica Scandinavica

    2023  Volume 102, Issue 12, Page(s) 1606–1607

    MeSH term(s) Humans ; Male ; Semen Analysis ; Fertility
    Language English
    Publishing date 2023-08-31
    Publishing country United States
    Document type Editorial
    ZDB-ID 80019-3
    ISSN 1600-0412 ; 0001-6349
    ISSN (online) 1600-0412
    ISSN 0001-6349
    DOI 10.1111/aogs.14693
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: ICSI outcome after microdissection testicular sperm extraction, testicular sperm aspiration and ejaculated sperm.

    Klami, Rauni / Tomás, Candido / Mankonen, Harri / Perheentupa, Antti

    Reproductive biology

    2023  Volume 24, Issue 1, Page(s) 100825

    Abstract: We conducted a case-controlled single-center cohort study to evaluate the intracytoplasmic sperm injection (ICSI) outcome in severe male infertility with different methods of sperm obtention. The data was compiled from a tertiary university hospital. The ...

    Abstract We conducted a case-controlled single-center cohort study to evaluate the intracytoplasmic sperm injection (ICSI) outcome in severe male infertility with different methods of sperm obtention. The data was compiled from a tertiary university hospital. The micro-TESE procedures were performed from 2008 to 2023, with a sperm recovery rate (SRR) of 45 %. The ICSI treatments were carried out between 2011 and 2023. The aim of the study was to compare the ICSI outcome using sperm obtained by microdissection testicular extraction (micro-TESE), testicular sperm aspiration (TESA), and ejaculated sperm with sperm concentration less than 15 million per milliliter. We included a total of 462 ICSI cycles, of which 340 ICSIs with ejaculated sperm of men with oligozoospermia, with or without asthenozoospermia or teratozoospermia (OAT group), 51 ICSIs with TESA sperm of men with obstructive azoospermia (OA, TESA group), and 71 ICSIs with micro-TESE sperm of men with non-obstructive azoospermia (NOA, micro-TESE group). The patient characteristics, fertilization rate, pregnancy rate, and pregnancy outcome data were similar between the groups. The fertilization rates were 66.0 % in the OAT group, 68.3 % in the TESA group and 62.8 % in the micro-TESE group and live birth rate per embryo transfer were 23.7 %, 28.9 %, and 25.0 %, respectively, without statistical difference. The obstetrical outcome was similar in all the groups. The overall clinical results in all ICSI cycles performed for treating severe male factor infertility were similar, independent of the method of collection of spermatozoa. The results also confirm the efficacy of micro-TESE in the treatment of severe male factor infertility.
    MeSH term(s) Female ; Humans ; Male ; Pregnancy ; Azoospermia/therapy ; Sperm Retrieval ; Sperm Injections, Intracytoplasmic/methods ; Microdissection/methods ; Cohort Studies ; Retrospective Studies ; Semen ; Spermatozoa ; Testis ; Infertility, Male
    Language English
    Publishing date 2023-11-24
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 2189316-0
    ISSN 2300-732X ; 1642-431X
    ISSN (online) 2300-732X
    ISSN 1642-431X
    DOI 10.1016/j.repbio.2023.100825
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book ; Thesis: Regulation of gonadotropin gene expression, synthesis and secretion by gonadal steroids, GnRH and starvation in the male rat

    Perheentupa, Antti

    (Turun Yliopiston julkaisuja : Sarja D ; 154)

    1994  

    Author's details by Antti Perheentupa
    Series title Turun Yliopiston julkaisuja : Sarja D ; 154
    Turun Yliopiston julkaisuja
    Turun Yliopiston julkaisuja ; Sarja D
    Collection Turun Yliopiston julkaisuja
    Turun Yliopiston julkaisuja ; Sarja D
    Language English
    Size Getr. Zählung : graph. Darst.
    Publisher Turun Yliopisto
    Publishing place Turku
    Publishing country Finland
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Turku, Univ., Diss., 1994
    HBZ-ID HT006839152
    ISBN 951-29-0324-5 ; 978-951-29-0324-5
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  6. Article ; Online: Oestrogen therapy for postpartum depression: efficacy and adverse effects. A double-blind, randomized, placebo-controlled pilot study.

    Kettunen, Pirjo / Koistinen, Eeva / Hintikka, Jukka / Perheentupa, Antti

    Nordic journal of psychiatry

    2021  Volume 76, Issue 5, Page(s) 348–357

    Abstract: Background: Postpartum depression (PPD) is detrimental to the mother and the family as a whole. Early initiation of appropriate treatment is important. The aim of this pilot study was to evaluate the efficacy and adverse effects of oestradiol treatment.! ...

    Abstract Background: Postpartum depression (PPD) is detrimental to the mother and the family as a whole. Early initiation of appropriate treatment is important. The aim of this pilot study was to evaluate the efficacy and adverse effects of oestradiol treatment.
    Methods: We performed a pilot double-blind, randomized, placebo-controlled study. Major depression was diagnosed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), and the severity of depression was evaluated using the Edinburgh Postnatal Depression Scale (EPDS). The duration of treatment with sublingual oestradiol hemihydrate (1-3 mg/day) was 12 weeks.
    Results: The treatment group consisted of 16 mothers and the placebo group of 14 mothers. Thirteen mothers in the treatment group and ten in the placebo group recovered from depression during the treatment period as measured with the EPDS (<10). There was no evidence to suggest that oestradiol was more effective than placebo. More mothers in the treatment group than in the placebo group (eight vs. one) received gestagen treatment for irregular bleeding. Oestradiol did not disturb breastfeeding. The mean number of other adverse effects per mother was lower in the treatment group, and these were mostly somatic symptoms.
    Conclusion: Our findings warrant further studies on oestrogen therapy for PPD with and without antidepressant and gestagen therapy, and on adverse effects (including effects on vaginal bleeding and breastfeeding).
    MeSH term(s) Depression, Postpartum/diagnosis ; Depression, Postpartum/drug therapy ; Estradiol/adverse effects ; Estradiol/therapeutic use ; Estrogens/adverse effects ; Estrogens/therapeutic use ; Female ; Humans ; Mothers ; Pilot Projects ; Postpartum Period ; Progestins/adverse effects ; Progestins/therapeutic use
    Chemical Substances Estrogens ; Progestins ; Estradiol (4TI98Z838E)
    Language English
    Publishing date 2021-09-17
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 1104974-1
    ISSN 1502-4725 ; 0803-9488 ; 0029-1455
    ISSN (online) 1502-4725
    ISSN 0803-9488 ; 0029-1455
    DOI 10.1080/08039488.2021.1974556
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Maternal risk factors for congenital limb deficiencies: A population-based case-control study.

    Syvänen, Johanna / Nietosvaara, Yrjänä / Hurme, Saija / Perheentupa, Antti / Gissler, Mika / Raitio, Arimatias / Helenius, Ilkka

    Paediatric and perinatal epidemiology

    2021  Volume 35, Issue 4, Page(s) 450–458

    Abstract: Background: Risk factors for congenital limb deficiencies are poorly understood.: Objective: To investigate risk factors for congenital limb deficiencies.: Methods: We conducted a nationwide population-based case-control (1:5) study in Finland, ... ...

    Abstract Background: Risk factors for congenital limb deficiencies are poorly understood.
    Objective: To investigate risk factors for congenital limb deficiencies.
    Methods: We conducted a nationwide population-based case-control (1:5) study in Finland, using national registers on congenital anomalies, births, and induced abortions, cross-linked with data on maternal prescription medicine use obtained from the registers on Reimbursed Drug Purchases and Medical Special Reimbursements. Five hundred and four children with limb deficiencies (241 isolated, 181 syndromic, and 82 other associated anomalies) were identified, and 2,520 controls were matched to cases on residence and year of pregnancy. Non-syndromic cases (n = 323) were subdivided into longitudinal (n = 120), transverse (n = 123), intercalary (n = 24), mixed (n = 18), and unknown (n = 38) deficiencies.
    Results: Pregestational diabetes was associated with all limb deficiencies (adjusted odds ratio [OR] 12.71, 95% confidence interval [CI] 2.37, 68.25) and with isolated (OR 11.42, 95% CI 2.00, 64.60) deficiencies. Primiparity was associated with increased risk of congenital limb deficiencies among all cases (OR 1.49, 95% CI 1.15, 1.93), isolated cases (OR 1.46, 95% CI 1.09, 1.96), and among cases with longitudinal (OR 1.90, 95% CI 1.24, 2.90) and transverse deficiencies (OR 1.75, 95% CI 1.13, 2.70). Young maternal age (<25 years) was associated with all congenital limb deficiencies (OR 1.40, 95% CI 1.02, 1.90) and transverse deficiencies (OR 1.76, 95% CI 1.05, 2.96). Advanced maternal age (≥35 years) was associated with syndromic (OR 1.82, 95% CI 1.19, 2.78) and transverse deficiencies (OR 1.94, 95% CI 1.06, 3.57). Maternal antiepileptic medication was associated with all (OR 5.77, 95% CI 1.75, 19.04) and with isolated cases (OR 3.83, 95% CI 1.02, 14.34).
    Conclusions: It is important that pregnant women taking medications, especially antiepileptics, or women with pregestational diabetes are carefully monitored with regard to the occurrence and risk of limb deficiencies in the fetus.
    MeSH term(s) Adult ; Case-Control Studies ; Child ; Female ; Humans ; Maternal Age ; Odds Ratio ; Parity ; Pregnancy ; Risk Factors
    Language English
    Publishing date 2021-01-13
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639089-4
    ISSN 1365-3016 ; 0269-5022 ; 1353-663X
    ISSN (online) 1365-3016
    ISSN 0269-5022 ; 1353-663X
    DOI 10.1111/ppe.12740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Successful microdissection testicular sperm extraction for men with non-obstructive azoospermia.

    Klami, Rauni / Mankonen, Harri / Perheentupa, Antti

    Reproductive biology

    2018  Volume 18, Issue 2, Page(s) 137–142

    Abstract: Non-obstructive azoospermia (NOA) is the most severe form of male infertility, defined by lack of spermatozoa in the ejaculate caused by impaired spermatogenesis. The chance of biological fatherhood of these men has been improved since the introduction ... ...

    Abstract Non-obstructive azoospermia (NOA) is the most severe form of male infertility, defined by lack of spermatozoa in the ejaculate caused by impaired spermatogenesis. The chance of biological fatherhood of these men has been improved since the introduction of microdissection testicular sperm extraction (MD-TESE) combined with intracytoplasmic sperm injection. A thorough patient evaluation preoperatively is essential to recognize any underlying conditions, and to assist in patient counseling on the sperm recovery rate and pregnancy results. This review article summarizes the present data on MD-TESE to reach optimal results is treating men with NOA.
    MeSH term(s) Azoospermia ; Female ; Humans ; Male ; Microdissection ; Pregnancy ; Pregnancy Rate ; Sperm Injections, Intracytoplasmic/methods ; Sperm Retrieval ; Testis
    Language English
    Publishing date 2018-03-27
    Publishing country Poland
    Document type Journal Article ; Review
    ZDB-ID 2189316-0
    ISSN 2300-732X ; 1642-431X
    ISSN (online) 2300-732X
    ISSN 1642-431X
    DOI 10.1016/j.repbio.2018.03.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Histone H3K4me3 breadth in hypoxia reveals endometrial core functions and stress adaptation linked to endometriosis.

    Rytkönen, Kalle T / Faux, Thomas / Mahmoudian, Mehrad / Heinosalo, Taija / Nnamani, Mauris C / Perheentupa, Antti / Poutanen, Matti / Elo, Laura L / Wagner, Günter P

    iScience

    2022  Volume 25, Issue 5, Page(s) 104235

    Abstract: Trimethylation of histone H3 at lysine 4 (H3K4me3) is a marker of active promoters. Broad H3K4me3 promoter domains have been associated with cell type identity, but H3K4me3 dynamics upon cellular stress have not been well characterized. We assessed this ... ...

    Abstract Trimethylation of histone H3 at lysine 4 (H3K4me3) is a marker of active promoters. Broad H3K4me3 promoter domains have been associated with cell type identity, but H3K4me3 dynamics upon cellular stress have not been well characterized. We assessed this by exposing endometrial stromal cells to hypoxia, which is a major cellular stress condition. We observed that hypoxia modifies the existing H3K4me3 marks and that promoter H3K4me3 breadth rather than height correlates with transcription. Broad H3K4me3 domains mark genes for endometrial core functions and are maintained or selectively extended upon hypoxia. Hypoxic extension of H3K4me3 breadth associates with stress adaptation genes relevant for the survival of endometrial cells including transcription factor KLF4, for which we found increased protein expression in the stroma of endometriosis lesions. These results substantiate the view on broad H3K4me3 as a marker of cell identity genes and reveal participation of H3K4me3 extension in cellular stress adaptation.
    Language English
    Publishing date 2022-04-12
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2022.104235
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Magnetic resonance guided high intensity focused ultrasound for uterine fibroids and adenomyosis has no effect on ovarian reserve.

    Otonkoski, Saara / Sainio, Teija / Mattila, Sami / Blanco Sequieros, Roberto / Perheentupa, Antti / Komar, Gaber / Joronen, Kirsi

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

    2022  Volume 40, Issue 1, Page(s) 2154575

    Abstract: Introduction: Uterine fibroids are the most common benign tumors in healthy women. High Intensity Focused Ultrasound (HIFU) is a modern, noninvasive thermal ablation method for treating uterine fibroids. There is increasing evidence that ultrasound ... ...

    Abstract Introduction: Uterine fibroids are the most common benign tumors in healthy women. High Intensity Focused Ultrasound (HIFU) is a modern, noninvasive thermal ablation method for treating uterine fibroids. There is increasing evidence that ultrasound guided HIFU (US-HIFU) has no adverse impact on ovarian reserve but little data exists on magnetic resonance guided HIFU (MR-HIFU). There are different options to estimate ovarian reserve, perhaps the most reliable being the measurement of serum Anti-Müllerian hormone (AMH).
    Material and methods: Seventy-four (74) premenopausal women with serum AMH 0.1 ug/L or over, aged 24-48 and with fibroids or adenomyosis treated with MR-HIFU were enrolled in our study. AMH levels were analyzed before and 3 months after the MR-HIFU treatment. Correlations between AMH level changes and position of fibroids, fibroid volume, non-perfused volume ratio, and treatment energies were studied.
    Results: The median AMH level before the HIFU treatment was 1.20 (range: 0.1-7.75 ug/L) and after the treatment 1.23 (range: 0.1-8.51 ug/L). No significant change was detected (
    Conclusions: MR-HIFU does not compromise the ovarian reserve. Neither the location of the treated fibroid nor the total energy used during MR-HIFU had any effect on the change of AMH levels.
    MeSH term(s) Humans ; Female ; Uterine Neoplasms/surgery ; Adenomyosis/therapy ; Ovarian Reserve ; Treatment Outcome ; Leiomyoma/surgery ; High-Intensity Focused Ultrasound Ablation/methods ; Magnetic Resonance Imaging/methods ; Magnetic Resonance Spectroscopy
    Language English
    Publishing date 2022-12-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632526-9
    ISSN 1464-5157 ; 0265-6736
    ISSN (online) 1464-5157
    ISSN 0265-6736
    DOI 10.1080/02656736.2022.2154575
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top